Product Information
CELLCEPT 200 MG/ML ORAL SUSP is a brand product labeled by Genentech, Inc., priced at $8.3178 per ML under NDC 00004026129. Its NADAC has been published 435 times since Nov 28, 2013.
FDA first approved this application on Oct 1, 1998. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Mycophenolate Mofetil market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
200 mg/mL
Manufacturer
Genentech, Inc.NDC
00004026129
Classification
Brand
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
MYCOPHENOLATE MOFETILApproval Type
New Drug (NDA)
FDA Application
NDA050759FDA Approved
10/1/1998
TE Code
AB
On Market Since
10/1/1998
Pharmacological Classes
Price Statistics
The NADAC for CELLCEPT 200 MG/ML ORAL SUSP has been published 435 times since Nov 28, 2013, and over the history we have for it it has risen 39.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.3178 per ML |
|---|---|
| All-time high | $8.4086 (Feb 13, 2019) |
| All-time low | $5.9684 (Nov 28, 2013) |
| 52-week high | $8.3454 |
| 52-week low | $8.3178 |
| Median price | $8.2776 |
| Average price | $7.7379 |
| Largest weekly change | +9.5% (Nov 18, 2015) |
| Weeks tracked | 435 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 89% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CELLCEPT 200 MG/ML ORAL SUSP?
The current National Average Drug Acquisition Cost (NADAC) for CELLCEPT 200 MG/ML ORAL SUSP, manufactured by Genentech, Inc., is $8.3178 per ML (NDC 00004026129), effective Aug 19, 2026.
How has the price of CELLCEPT 200 MG/ML ORAL SUSP changed over time?
Over the history we have for it, the NADAC for CELLCEPT 200 MG/ML ORAL SUSP has risen 39.4%. It has been tracked across 435 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CELLCEPT 200 MG/ML ORAL SUSP?
Since Nov 28, 2013, the NADAC for CELLCEPT 200 MG/ML ORAL SUSP has ranged from a low of $5.9684 (Nov 28, 2013) to a high of $8.4086 (Feb 13, 2019), with a median of $8.2776 per ML.
Are there cheaper alternatives to CELLCEPT 200 MG/ML ORAL SUSP?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, MYCOPHENOLATE 200 MG/ML SUSP, is $0.9440 per ML — about 89% below CELLCEPT 200 MG/ML ORAL SUSP.
Who manufactures CELLCEPT 200 MG/ML ORAL SUSP?
CELLCEPT 200 MG/ML ORAL SUSP (NDC 00004026129) is labeled by Genentech, Inc., and CMS classifies it as a brand product.